BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

CUSIP: 07782B104

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding
37,379,062
Total 13F shares
78,699
Share change
-107,869
Total reported value
$3,689,407
Price per share
$46.88
Number of holders
15
Value change
-$4,872,726
Number of buys
11
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARMISTICE CAPITAL, LLC
13F
Company
0.4%
148,000
$6,760,640 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.04%
15,671
$715,851 30 Jun 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.02%
7,311
$333,966 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
6,700
$306,056 30 Jun 2024
13F
HRT FINANCIAL LP
13F
Company
0.01%
5,409
$247,000 30 Jun 2024
13F
VIRTUS ADVISERS, LLC
13F
Company
0%
1,807
$82,544 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0%
1,044
$47,690 30 Jun 2024
13F
GAMMA Investing LLC
13F
Company
0%
428
$19,551 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
102
$4,659 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
88
$4,020 30 Jun 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
8
$365 30 Jun 2024
13F

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q3 2024

As of 30 Sep 2024, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 78,699 shares. The largest 10 holders included STATE STREET CORP, BANK OF AMERICA CORP /DE/, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, XTX Topco Ltd, Point72 Asset Management, L.P., Cubist Systematic Strategies, LLC, and Virtus ETF Advisers LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
11
Q3 2024 holders
15
Holder diff
4
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .